DR Congo Vaccinates Health Workers Against Ebola as Death Toll Climbs

Healthcare professionals in the Democratic Republic of the Congo have started receiving a vaccine aimed at protecting them against the ongoing Ebola outbreak. The immunization campaign began on Saturday in Bunia, the capital of Ituri province, which is currently the epicenter of what is being described as the fastest-growing Ebola outbreak in recorded history.

Authorities are also targeting North Kivu province, where case numbers have surged recently. Approximately 50,000 frontline health and support workers are scheduled to receive the Ervebo vaccine, which was originally developed to combat the more common Zaire strain of the virus. Clinical trials are continuing in an effort to identify a licensed vaccine and proven treatment specifically for the current outbreak, which is caused by the Bundibugyo strain and currently lacks both.

The initiative is supported by the World Health Organization (WHO) and Doctors Without Borders (MSF). Dr. Jeannot Elua, speaking from a health facility in Bunia, described the vaccine as beneficial. “We healthcare workers don’t really have a choice. We are going to receive it,” he told the Associated Press, noting that he had already received a previous mandatory vaccine.

Steve Ahuka, a member of the Congolese health task force, acknowledged the uncertainty surrounding the vaccine’s efficacy against the current strain. “We don’t know to what degree it might be effective against the Bundibugyo strain,” he stated. However, WHO experts noted that early data, particularly from animal trials, suggests the vaccine may offer some protection.

The emergency use of Ervebo is being conducted under a compassionate-use program, which permits the administration of medical products in serious disease scenarios even when they lack specific approval for that particular situation. In August, the WHO approved 70,000 doses for deployment in the DRC.

Local health authorities report that the virus has infected approximately 7,541 people since May, resulting in at least 3,639 deaths. There are currently 1,823 recovered patients. Effectiveness of the vaccine against the Bundibugyo virus will be monitored among 20,000 recipients for up to one year.

Major-General Gaby Kasongo Mulumba, the provincial governor of Ituri, emphasized the vulnerability of medical staff. “Health workers there are particularly exposed and deeply involved in the response,” he said.

While WHO officials have expressed cautious optimism in August, citing encouraging signs that transmission rates may be slowing, MSF warned recently that there is no definitive evidence the epidemic is coming under control.